# Teligene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/teligene

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.teligenebio.cn
- Latest round: Series C (Aug 17, 2018)
- Investors on record: 10

## About

Based in Suzhou, China and established in 2011, SuZhou Teligene, Ltd. is a biotechnology company that develops small molecule new drugs for cancer treatment. The company was founded by Amgen's chief scientist, Dawei Zhang. It has established several subsidiaries, including Jiangsu Maidu Pharmaceutical Research and Development Co., Ltd., Shanghai Taoluo Biotechnology Co., Ltd., and Jiangsu Maidu Pharmaceutical Research and Development Co., Ltd. In February 2021, Teligene Ltd raised USD 93 million in pre-IPO funding.

The company is committed to developing anti-tumour therapeutics with its own intellectual property rights. Its product line covers several pipeline projects, with major products such as EGFR small molecule inhibitors Sutentinib, TL118 and Cernetinib.

The company generates revenue by providing anti-tumour therapeutic drugs such as Sutentinib.

## Funding rounds

- Series C, Aug 17, 2018 — IDG Capital, GTJA Investment Group, Loyal Valley Capital, Qianhai Hongfu
- Series B, Jul 6, 2017 — Shenzhen Capital Real Estate Fund, CCB Private Equity Investment Management, China Universal Capital Investment Fund, Medolution Limited, Suzhong Pharma, Jiangsu Kangsier Medical Technology

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B
- CCB Private Equity Investment Management (https://capitalatlas.ai/funds/ccb-private-equity-investment-management) — Series B
- China Universal Capital Investment Fund (https://capitalatlas.ai/funds/china-universal-capital-investment-fund) — Series B
- Medolution Limited — Series B
- Suzhong Pharma — Series B
- Jiangsu Kangsier Medical Technology — Series B
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series C
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series C
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series C
- Qianhai Hongfu — Series C